Imarx Pharmaceutical Corporation

Other

Imarx Therapeutics, Inc.

Nuvox Pharma LLC

Bristol-myers Squibb Medical Imaging, Inc.

Imar.sub.x Pharmaceutical Corp.

Bristol-myers Squibb Pharma Company

Microvascular Therapeutics LLC

The Dupont Merck Pharmaceutical Company

Bioventures, LLC

Microvascuar Therapeutics LLC

Imarx Pharaceutical Corp.

Imarx Pharmaceuticals Corp.

Lantheus Medical Imaging, Inc.

Unger, Evan, C.

Evan C Unger

Guanli Wu

David W Yellowhair

Terry Onichi Matsunaga

Thomas A Fritz

VaradaRajan Ramaswami

DeKang Shen

Thomas McCreery

Yunqiu Wu

Edmund R Marinelli

Frederick Scott Pereles

Daniel C Evans

Edward W Gertz

Terrence R Barrette

Robert D Skinner

William C Culp

Jennifer L Johnson

Thomas P Mc Creery

Patrick W Hendon

Patricia A Schumann

Ed Marinelli

William Culp

Robert Skinner

Terry O Matsunaga

Varada Rajan Ramaswami

A fluorocarbon emulsion in water for use in fractionated radiotherapy and chemotherapy, wherein said fluorocarbon comprises between 4 and 8 carbon atoms.

Fractionated radiotherapy and chemotherapy with an oxygen therapeutic

The invention provides devices and methods for adjusting particle size in nanoemulsions of fluorocarbons and perfluorocarbons (e.g., perfluoropentane and perfluorohexane) via sonication (e.g., ultrasonication).

Adjusting particle size in fluorocarbon nanoemulsions

The present invention provides methods and combinations for reducing the infarct volume in a tissue of a subject undergoing ischemia or at risk of developing ischemia.

Dodecafluoropentane emulsion as a stroke and ischemia therapy

The invention provides novel compositions of fluorocarbon nanoemulsions comprising one or more of fluorosurfactants and phospholipids, and methods of preparation and use thereof for enhanced oxygen delivery.

Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof

A composition, and method thereof, for stabilizing a fluorocarbon emulsion includes phosphatidylcholine, phosphatidylethanolamine-PEG, and a cone-shaped lipid.

Phospholipid composition and microbubbles and emulsions formed using same

A method of forming a plurality of microbubbles, wherein the method disposes in a sealed container comprising a first volume at ambient pressure, a second volume of a mixture comprising one or more microbubble stabilizing materials. The first volume is greater than said second volume. The method further comprises sealing said container, introducing a gas into said sealed container, and shaking the container to form said plurality of microbubbles.

Microbubble compositions, method of making same, and method using same

An oxygen therapeutic composition, which includes a perfluorocarbon material having a boiling point of about 4 degrees Celsius to about 60 degrees Celsius, a lipid; a viscosity modifier; a buffer.

Buffered oxygen therapeutics

A composition for stabilizing a fluorocarbon emulsion. That composition includes phosphatidylcholine, phosphatidylethanolamine-PEG, and a cone-shaped lipid.

Buffered oxygen therapeutic

An oxygen therapeutic composition, comprising a perfluorocarbon material, a viscosity modifier, a buffer, wherein the buffer stabilizes a pH of the composition at between about 6.5 to about 7.5, and wherein the composition comprises a viscosity of about 2.0 to about 3.5 mPas, and wherein the fluorocarbon has a boiling point of about 4 degrees Celsius to about 60 degrees Celsius.

Growing community of inventors

Tucson, AZ, United States of America

Evan C Unger